Brain inhibition study in people with multiple sclerosis
Part of Brain & nervous system, Immune system & allergy clinical trials.
This trial uses brain stimulation and MRI to study how the brain controls muscle movement in people with relapsing-remitting MS. Researchers want to understand changes in brain 'inhibition' (a natural stopping signal) that might affect walking or thinking.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have relapsing-remitting MS diagnosed by the 2017 McDonald criteria.
- You must be able to walk without much help (EDSS score of 6.5 or less).
- You must be on a stable MS medication for at least 3 months, or not be taking any MS medicine.
- You must not have had a relapse or steroid treatment in the last 3 months.
- You must not have other brain disorders, seizures, metal implants, or severe vision or thinking problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a noninvasive brain stimulation technique (rTMS) can help people with multiple sclerosis who have leg stiffness and weakness. You will receive daily sessions over two weeks to see if it improves walking and quality of life.
This trial tests whether a brain-computer interface using motor imagery can help people with multiple sclerosis. You would imagine moving your limbs while the system translates that into feedback, potentially improving movement or spasticity.
This study tests a non-invasive brain stimulation technique called cerebellar tDCS to help improve movement, thinking, and daily functioning in people with multiple sclerosis. The treatment involves placing electrodes on your scalp to deliver mild electrical current, which may help reduce symptoms like balance problems and cognitive difficulties.
This study tests whether a gentle electrical current applied to the scalp (called tDCS) can help people with multiple sclerosis. It involves brain stimulation sessions and MRI scans to see if the treatment improves symptoms or brain function.
This trial uses brain MRI and eye imaging tests to study research markers in people with multiple sclerosis (MS) and related neurologic conditions. It may help researchers better understand these diseases and how they change over time.
This study tests whether transcranial magnetic stimulation (TMS)—a non-invasive procedure that uses magnetic pulses to stimulate the brain—can help treat depression in people with multiple sclerosis who haven't benefited enough from antidepressants or therapy. The goal is to see if TMS is safe and effective for this specific group.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.